Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May 12:15:203-11.
doi: 10.12659/AJCR.890229. eCollection 2014.

Weight change therapy as a potential treatment for end-stage ovarian carcinoma

Affiliations

Weight change therapy as a potential treatment for end-stage ovarian carcinoma

Kuat Pernekulovich Oshakbayev et al. Am J Case Rep. .

Abstract

Patient: Female, 41 FINAL DIAGNOSIS: Ovarian carcinoma Symptoms: Ascites • hepatomegaly • weight loss

Medication: - Clinical Procedure: - Specialty: Oncology.

Objective: Unusual or unexpected effect of treatment.

Background: The aim of this case report is to present the results of treatment of end-stage ovarian carcinoma in a 41-year-old women using weight loss therapy.

Case report: We describe the case of a female aged 41 years with epithelial invasive ovarian cancer of III-IV stage, T3N2M1. Concurrent diseases were: abdominal carcinomatosis; hepatomegaly; ascites; condition after laparocentesis and skin-abdominal fistula; condition after 6 courses of neo-adjuvant polychemotherapy; hypertension II stage, risk factor of 3-4; dyslipidemia; and metabolic syndrome. A weight loss method based on a very-low-calorie diet and physical activity was used. Body weight was reduced from 74 kg to 53 due to loss of adipose tissue after 6 months of therapy. At the same time, the percentages of water and muscle tissue were increased significantly. While overweight was reducing, clinical, laboratory, and instrumental results were improving. As a result of the weight loss therapy, about ≈100 mm-sized ovarian cancer was transformed into smaller-sized ovarian cysts.

Conclusions: An analgesic effect was also achieved without use of narcotic or non-narcotic analgesics. These cyto-reversible processes were documented by laboratory and instrumental data. The mechanisms behind these differences remain to be elucidated. Future research with a larger study cohort and longer follow-up is needed to further investigate the role of caloric restriction diet in cancer cell changes in ovarian cancer.

Keywords: Metabolic Syndrome X; Ovarian Neoplasms; Weight Loss.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Ultrasound images of the right (A) and left (B) ovaries on August 24, 2012.
Figure 2.
Figure 2.
Ultrasound images of the right and left ovaries on November 23, 2012.
Figure 3.
Figure 3.
Ultrasound images of the right and left ovaries on September 12, 2013.

Similar articles

Cited by

References

    1. Schnipper LE, Smith TJ, Raghavan D, et al. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: The top five list for oncology. J Clin Oncol. 2012;30:1715–24. - PubMed
    1. Health of population of the Republic of Kazakhstan and activity of health organizations in 2010–1012 years (statistical material) Vol. 2013. Astana: Medinform; p. 346.
    1. Lutz S, Berk L, Chang E, et al. Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011;79:965–76. - PubMed
    1. Parmar MK, Ledermann JA, Colombo N, et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet. 2003;361(9375):2099–106. - PubMed
    1. Hu Y-Y, Kwok AC, Jiang W, et al. High-Cost Imaging in Elderly Patients With Stage IV Cancer. J Natl Cancer Inst. 2012;104(15):1165–73. - PMC - PubMed

LinkOut - more resources